Literature DB >> 11712752

Human muscle voltage-gated ion channels and hereditary disease.

K Jurkat-Rott1, F Lehmann-Horn.   

Abstract

Insights in the field of ion channels were made possible by the Nobel-prize-winning patch-clamp technique that enables characterization of channel function, and have greatly been inspired by associated diseases pointing to regions of functional significance. These so-called ion channelopathies have common clinical features, recurrent patterns of mutations, and almost predictable mechanisms of pathogenesis. In skeletal muscle, disorders are associated with mutations in Na+, K+, Ca2+, and Cl- channels that lead to hypoexcitability (causing periodic paralysis) and to hyperexcitabilty (causing myotonia or susceptibility to malignant hyperthermia).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11712752     DOI: 10.1016/s1471-4892(01)00050-9

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  10 in total

1.  Structural effects of an LQT-3 mutation on heart Na+ channel gating.

Authors:  M Tateyama; H Liu; A-S Yang; J W Cormier; R S Kass
Journal:  Biophys J       Date:  2004-03       Impact factor: 4.033

2.  Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1.

Authors:  E L Logigian; W B Martens; R T Moxley; M P McDermott; N Dilek; A W Wiegner; A T Pearson; C A Barbieri; C L Annis; C A Thornton; R T Moxley
Journal:  Neurology       Date:  2010-05-04       Impact factor: 9.910

Review 3.  Behavior of KCNQ Channels in Neural Plasticity and Motor Disorders.

Authors:  Som P Singh; Matthew William; Mira Malavia; Xiang-Ping Chu
Journal:  Membranes (Basel)       Date:  2022-05-06

4.  Inhibition of skeletal muscle sodium currents by mexiletine analogues: specific hydrophobic interactions rather than lipophilia per se account for drug therapeutic profile.

Authors:  Annamaria De Luca; Sophie Talon; Michela De Bellis; Jean-François Desaphy; Carlo Franchini; Giovanni Lentini; Alessia Catalano; Filomena Corbo; Vincenzo Tortorella; Diana Conte-Camerino
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-01-25       Impact factor: 3.000

5.  In silico investigations on functional and haplotype tag SNPs associated with congenital long QT syndromes (LQTSs).

Authors:  C Sudandiradoss; Rao Sethumadhavan
Journal:  Genomic Med       Date:  2009-02-12

6.  Comparisons of mass spectrometry compatible surfactants for global analysis of the mammalian brain proteome.

Authors:  Emily I Chen; Daniel McClatchy; Sung Kyu Park; John R Yates
Journal:  Anal Chem       Date:  2008-10-21       Impact factor: 6.986

7.  The neonatal splice variant of Nav1.5 potentiates in vitro invasive behaviour of MDA-MB-231 human breast cancer cells.

Authors:  William J Brackenbury; Athina-Myrto Chioni; James K J Diss; Mustafa B A Djamgoz
Journal:  Breast Cancer Res Treat       Date:  2006-07-13       Impact factor: 4.872

8.  Searching for novel anti-myotonic agents: pharmacophore requirement for use-dependent block of skeletal muscle sodium channels by N-benzylated cyclic derivatives of tocainide.

Authors:  Annamaria De Luca; Michela De Bellis; Filomena Corbo; Carlo Franchini; Marilena Muraglia; Alessia Catalano; Alessia Carocci; Diana Conte Camerino
Journal:  Neuromuscul Disord       Date:  2011-07-29       Impact factor: 4.296

9.  Short-Communication: Variable Expression of Clinical Symptoms and an Unexpected Finding of Vacuolar Myopathy Related to a Pathogenic Variant in the CACNA1S Gene in a Previous Case Report.

Authors:  Edmar O Benítez-Alonso; Juan C López-Hernández; Javier A Galnares-Olalde; Raúl E Alcalá; Edwin S Vargas-Cañas
Journal:  Cureus       Date:  2022-04-02

10.  Pathways affected by asbestos exposure in normal and tumour tissue of lung cancer patients.

Authors:  Salla Ruosaari; Tuija Hienonen-Kempas; Anne Puustinen; Virinder K Sarhadi; Jaakko Hollmén; Sakari Knuutila; Juha Saharinen; Harriet Wikman; Sisko Anttila
Journal:  BMC Med Genomics       Date:  2008-11-11       Impact factor: 3.063

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.